Roche Investments

Roche has invested in 16 companies and its latest investment was Freenome on Feb 14, 2024

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Freenome is a California-based biotechnology company that researches and develops blood tests for the early detection of cancer.
$254M
Feb 14, 2024
-
Freenome is a California-based biotechnology company that researches and develops blood tests for the early detection of cancer.
$290M
Jan 10, 2022
-
Bonum is a Washington-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$1.2M
Dec 17, 2021
-
Amunix is a California-based biotechnology company that develops and markets T-cell and cytokine therapies for the treatment of cancer.
$40M
Jan 09, 2020
-
Biodesy develops a novel system to analyze real-time protein function for research and clinical applications.
$20M
Sep 09, 2018
-

Frequently Asked Questions about Roche

  1. What is Roche investing in?

    Roche has invested in 16 companies including Freenome, Freenome and Bonum
  2. What company did Roche invest in?

    Roche invested in a total 16 companies including Freenome, Freenome and Bonum
  1. What are the top 5 investments by Roche?

    The top companies in which Roche invested are Freenome, Freenome, Bonum, Amunix and Biodesy